Detailed price information for Ardelyx Inc (ARDX-Q) from The Globe and Mail including charting and trades. Ardelyx, Inc. discovers, develops, and commercializes minimally-systemic small molecule therapeutics for the gastrointestinal (GI) tract to treat cardio-renal, GI, and metabolic diseases. Its lead product candidate is tenapanor, a small molecule NHE3 inhibitor, Ardelyx—Ardelyx™ seeks to develop therapeutics that act exclusively in the gastrointestinal tract and that are devoid of systemic exposure. Its drug candidates target important diseases, as well as pathologies with a specific inflammatory pathway. Its technology relies on non-absorbable small molecules with highly specific modes of action. Ardelyx to Present at the Jefferies 2020 Virtual Healthcare Conference May 26 2020; Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 21 2020 Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial Officer May 18 2020; Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights May 07 2020
ARDX stock rating and analysis - Ardelyx : a summary of key financial strength and profitability metrics.
Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference PR Newswire: Feb-19-20 08:00AM : Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference PR Newswire: Dec-31-19 05:16AM : How Ardelyx, Inc. (NASDAQ:ARDX) Can Impact Your Portfolio Volatility Simply Wall St. Dec-05-19 07:14AM Find the latest press releases from Ardelyx, Inc. Common Stock (ARDX) at Nasdaq.com. In the historical earnings table above, in the column labeled "Implied Straddle", you will see the percentage move that was expected for the earnings based on the options at-the-money straddle price. Furthermore, you can see a before and after price effect comparison in ARDX earnings. ARDX stock rating and analysis - Ardelyx : a summary of key financial strength and profitability metrics. Ardelyx has also developed a number of programs directed toward treating gastrointestinal, or GI, disorders, including the treatment of irritable bowel syndrome with constipation, or IBS-C. The company's portfolio is led by the development of tenapanor, a first-in-class inhibitor of NHE3. Ardelyx develops novel, first-in-class oral therapeutics to correct mineral metabolism and metabolic disorders. The Company's molecules, whose systemic exposure is severely restricted, target transporters and receptors, modulating the uptake of nutrients or inducing secretion of key hormones to produce a therapeutic benefit in patients. Ardelyx General Information Description. Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has …
Ardelyx (ARDX) Reports Q4 Loss, Tops Revenue Estimates From Zacks Investment Research Mar 6, 2020 Ardelyx (ARDX) delivered earnings and revenue surprises of 17.65% and 221.43%, respectively, for
Find the latest Ardelyx, Inc. (ARDX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Discover historical prices for ARDX stock on Yahoo Finance. View daily, weekly or monthly format back to when Ardelyx, Inc. stock was issued. Find the latest Ardelyx, Inc. (ARDX) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Find the latest Ardelyx, Inc. (ARDX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
Ardelyx (ARDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy). Analysts Find the latest Ardelyx, Inc. (ARDX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Discover historical prices for ARDX stock on Yahoo Finance. View daily, weekly or monthly format back to when Ardelyx, Inc. stock was issued. Find the latest Ardelyx, Inc. (ARDX) stock discussions in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 11 May 2020 Ardelyx (ARDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 Xem thêm thông tin chi tiết về Cổ Phiếu Yahoo Japan (4689) bao gồm Giá Cả, Biểu Đồ, Phân Tích Kỹ Thuật, dữ liệu Lịch Sử, các Báo Cáo Yahoo Japan và hơn Find the latest Ardelyx, Inc. (ARDX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Find the latest Square, Inc. (SQ) stock quote, history, news and other vital information to help you with your stock trading and investing.
Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 18, 2020. Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial Officer. May 07, 2020. Ardelyx Reports First Quarter 2020 Financial … Ardelyx, Inc. Common Stock (ARDX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The Investor Relations website contains information about Ardelyx, Inc.'s business for stockholders, potential investors, and financial analysts. Ardelyx, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Ardelyx, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Ardelyx, Inc. or its management. Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference PR Newswire: Feb-19-20 08:00AM : Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference PR Newswire: Dec-31-19 05:16AM : How Ardelyx, Inc. (NASDAQ:ARDX) Can Impact Your Portfolio Volatility Simply Wall St. Dec-05-19 07:14AM Find the latest press releases from Ardelyx, Inc. Common Stock (ARDX) at Nasdaq.com. In the historical earnings table above, in the column labeled "Implied Straddle", you will see the percentage move that was expected for the earnings based on the options at-the-money straddle price. Furthermore, you can see a before and after price effect comparison in ARDX earnings.